HERMAB 440 MG PO LIOF SOL INJ IV CT FA VD TRANS
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1004314940020 -
GGREM
508024060182407 -
Código de barras
7891317028503
O que a fonte publica
- Detentor do registro
- EUROFARMA LABORATORIOS S.A.
- Princípios ativos
- TRASTUZUMABE
- Embalagem
- 440 MG PO LIOF SOL INJ IV CT FA VD TRANS
- Tipo de produto
- Biológico
- Classe terapêutica
- L1G3 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, HER-2
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "HERMAB 440 MG PO LIOF SOL INJ IV CT FA VD TRANS",
"holder": "EUROFARMA LABORATORIOS S.A.",
"stripe": null,
"barcodes": [
"7891317028503"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "508024060182407",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "61.190.096/0001-92",
"priceRegime": "Regulado",
"productName": "HERMAB",
"productType": "Biológico",
"hospitalOnly": true,
"presentation": "440 MG PO LIOF SOL INJ IV CT FA VD TRANS",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "9976.69",
"icms-12": "11337.15",
"icms-17": "12020.11",
"icms-18": "12166.69",
"icms-19": "12316.90",
"icms-20": "12470.86",
"icms-21": "12628.72",
"icms-22": "12790.63",
"icms-23": "12956.74",
"icms-17.5": "12092.96",
"icms-19.5": "12393.40",
"icms-20.5": "12549.30",
"icms-22.5": "12873.15",
"icms-12-alc": "11201.10",
"icms-17-alc": "11875.86",
"icms-18-alc": "12020.69",
"icms-19-alc": "12169.10",
"icms-20-alc": "12321.20",
"icms-21-alc": "12477.18",
"icms-22-alc": "12637.13",
"icms-23-alc": "12801.25",
"withoutTaxes": "9856.97",
"icms-17.5-alc": "11947.83",
"icms-19.5-alc": "12244.68",
"icms-20.5-alc": "12398.70",
"icms-22.5-alc": "12718.67"
},
"pisCofinsList": "Positiva",
"substanceText": "TRASTUZUMABE",
"targetSpecies": [],
"consumerPrices": null,
"invalidBarcodes": [],
"activeSubstances": [
"TRASTUZUMABE"
],
"therapeuticClass": "L1G3 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, HER-2",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1004314940020",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "L1G3",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:508024060182407"